Journal of Huntington's Disease (JHD)

The Journal of Huntington’s Disease (JHD) is a peer-reviewed international scientific journal devoted exclusively to research on Huntington’s disease (HD) — a hereditary, progressive neurodegenerative disorder characterized by motor dysfunction, cognitive decline, and psychiatric sequelae. Established in 2012 and published quarterly, JHD serves as a dedicated forum for original research, clinical studies, translational science, and comprehensive reviews that deepen understanding of the disease’s biological basis, clinical course, and therapeutic strategies. The journal welcomes contributions that span basic science, molecular genetics, neurobiology, pharmacological research, diagnostic methodology, clinical trials, and therapeutic development. It also provides space for letters, short communications, and commissioned reviews that enhance dialogue among clinicians, researchers, and policymakers working on HD and related conditions. JHD aims not only to elucidate underlying disease mechanisms but also to bridge laboratory discoveries with clinical applications, thereby accelerating progress toward effective treatments and improved patient outcomes. Indexed in major scholarly databases including PubMed/MEDLINE, Scopus, and Emerging Sources Citation Index, the journal has become a recognized outlet within the neurology and neuroscience community dedicated to Huntington’s disease research worldwide.

Journal of Huntington's Disease (JHD) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cellular and Molecular Neuroscience, General Medicine, Neurology, molecular correlates, pharmacology, diagnosis , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1879-6397, E-ISSN: 1879-6400, Established: 2012, Impact Factor: 3.1
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE